Brain volume and neuropsychological performance in HIV-1 patient cohort
Patient | Age(y) | Sex | CD4 (cells/μL) | Plasma RNA(copies/mL) | Brain Volume(cm3) | CSF Volume(cm3) | PBV | Total Memory | Motor Speed | Processing Speed | Total Mood | NPZ-8 | ADC Stage | HAART |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | 40 | F | 16 | 323,000 | 974.4 | 257.0 | .791 | 37 | 6 | 9 | 306 | 12 | 0.5 | − |
2 | 45 | M | 324 | 56,200 | 1,251.8 | 348.0 | .782 | 31 | 2 | 4 | 307 | 5 | 0.5 | + |
3 | 43 | M | 256 | 40,600 | 830.2 | 454.0 | .646 | 31 | 4 | 0 | 271 | 3 | 0.5 | + |
4 | 56 | M | 563 | ND | 1,049.7 | 369.0 | .740 | 41 | 5 | 3 | 296 | 5 | 0.5 | + |
5 | 44 | M | 321 | <50 | 1,094.7 | 266.4 | .804 | 39 | 2 | 0 | 306 | 2 | 0.5 | + |
6 | 45 | M | 190 | <20 | 1,605.4 | 264.5 | .858 | 32 | 1 | 7 | 344 | 6 | 1 | + |
7 | 45 | M | 818 | ND | 1,001.5 | 372.3 | .729 | 31 | 5 | 8 | 259 | 8 | 1 | + |
8 | 33 | M | 355 | <20 | 1,294.2 | 317.6 | .803 | 63 | 0 | 0 | 240 | 0 | 0 | + |
9 | 40 | M | 465 | <400 | 1,179.7 | 239.1 | .831 | 31 | 0 | 4 | 282 | 3 | 0 | + |
10 | 37 | M | 519 | <20 | 1,264.1 | 265.3 | .826 | 44 | 0 | 0 | 215 | 0 | 0 | + |
11 | 39 | M | 87 | 20,800 | 1,211.8 | 329.9 | .786 | 54 | 0 | 3 | 280 | 0 | 0 | + |
12 | 28 | F | 108 | 15,524 | 1,009.2 | 134.5 | .882 | ND | ND | ND | ND | 7 | 0 | + |
13 | 25 | M | 190 | 155,613 | 1,228.8 | 153.4 | .889 | 49 | 1 | 1 | 264 | 3 | 0 | + |
14 | 30 | F | 573 | <50 | 1,118.7 | 101.7 | .917 | 33 | 0 | 0 | 288 | 0 | 0 | + |
15 | 38 | M | 1,032 | <20 | 1,342.2 | 174.4 | .885 | 25 | 0 | 0 | 283 | 0 | 0 | + |
16 | 36 | F | 1,112.4 | 142.9 | .886 | 60 | 0 | 0 | 292 | 0 | 0 | − | ||
17 | 22 | M | 1,093.1 | 218.9 | .833 | 47 | 0 | 0 | 243 | 0 | 0 | − | ||
18 | 35 | F | 1,155.5 | 203.6 | .851 | 56 | 0 | 1 | 255 | 1 | 0 | − | ||
19 | 45 | F | 1,089.4 | 125.7 | .897 | 38 | 0 | 0 | 244 | 0 | 0 | − | ||
20 | 45 | M | 1,228.4 | 134.8 | .901 | 35 | 0 | 2 | 294 | 0 | 0 | − |
Note.—CD4 indicates cluster of differentiation 4; PBV, percentage of parenchymal brain volume; ADC, AIDS dementia complex; HAART, highly active antiretroviral therapy; ND, no data.